RecruitingNCT03887715

Comparing vagus nerve stimulation with no stimulation for resistant depression

About this title

Device studyAges 18+United States

The study in practice

Understand this study

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations: Birmingham and 100 more locationsSee all locations and recruitment

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: September 26, 2019

Recruitment status: Recruiting
Enrollment listed in the registry: 6,800
Sponsor: LivaNova
Sponsor type: Unknown or unclear
Study type: Device
Intervention type: DEVICE
Study phase: Not clearly listed
Locations: United States
Age range: Over 18 Years
Official registry ID: NCT03887715
Official title: Show the full official title
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Recruiting

Birmingham · Huntsville · Burlingame

85 more locations

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is LivaNova.

Who can participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.